RedHill Biopharma Ltd - Company Profile (NASDAQ:RDHL)

About RedHill Biopharma Ltd -

RedHill Biopharma Ltd - logoRedHill Biopharma Ltd. is a biopharmaceutical company primarily focused on the development of late clinical-stage, orally-administered, small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers. The Company's pipeline of products includes RHB-105, RHB-104, BEKINDA (RHB-102), RHB-106, ABC294640, MESUPRON, RP101 and RIZAPORT (RHB-103).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: RDHL
  • CUSIP:
Key Metrics:
  • Previous Close: $14.74
  • 50 Day Moving Average: $15.00
  • 200 Day Moving Average: $12.66
  • 52-Week Range: $8.10 - $16.54
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -14.31
  • P/E Growth: 0.00
  • Market Cap: $187.70M
  • Outstanding Shares: 12,734,000
  • Beta: 0.44
Additional Links:
Companies Related to RedHill Biopharma Ltd -:

Analyst Ratings

Consensus Ratings for RedHill Biopharma Ltd - (NASDAQ:RDHL) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $29.00 (96.74% upside)

Analysts' Ratings History for RedHill Biopharma Ltd - (NASDAQ:RDHL)
Show:
DateFirmActionRatingPrice TargetDetails
9/9/2016FBR & CoReiterated RatingBuyView Rating Details
3/29/2016NomuraReiterated RatingBuyView Rating Details
2/28/2016HC WainwrightReiterated RatingBuy$33.00View Rating Details
2/27/2016Roth CapitalReiterated RatingBuyView Rating Details
11/11/2015Ascendiant Capital MarketsLower Price TargetBuy$28.00 -> $26.00View Rating Details
9/29/2015Northland SecuritiesInitiated CoverageBuy$25.00View Rating Details
7/2/2015MLV & Co.Initiated CoverageBuy$33.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for RedHill Biopharma Ltd - (NASDAQ:RDHL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/27/2016Q116($0.58)($0.06)ViewListenView Earnings Details
4/20/2016Q1($0.48)$0.04ViewListenView Earnings Details
11/9/2015Q315($0.51)($0.04)ViewN/AView Earnings Details
7/29/2015Q215($0.49)($0.07)ViewListenView Earnings Details
4/30/2015Q115($0.56)($0.50)ViewN/AView Earnings Details
2/26/2015Q414($0.60)$0.06ViewN/AView Earnings Details
11/10/2014($0.61)($0.50)ViewN/AView Earnings Details
7/24/2014($0.38)($0.52)ViewN/AView Earnings Details
6/6/2014($0.44)$0.39ViewN/AView Earnings Details
4/30/2014($0.44)$0.39ViewN/AView Earnings Details
11/12/2013Q3 13($0.62)($0.04)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for RedHill Biopharma Ltd - (NASDAQ:RDHL)
Current Year EPS Consensus Estimate: $-2.06 EPS
Next Year EPS Consensus Estimate: $-1.03 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.49)($0.49)($0.49)
Q2 20161($0.54)($0.54)($0.54)
Q3 20162($0.61)($0.53)($0.57)
Q4 20162($0.63)($0.34)($0.49)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for RedHill Biopharma Ltd - (NASDAQ:RDHL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for RedHill Biopharma Ltd - (NASDAQ:RDHL)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for RedHill Biopharma Ltd - (NASDAQ:RDHL)
DateHeadline
globenewswire.com logoRedHill Biopharma to Present at the BioNetwork West 2016 ... - GlobeNewswire (press release) (NASDAQ:RDHL)
globenewswire.com - September 27 at 11:36 AM
finance.yahoo.com logoRedHill Biopharma to Present at the BioNetwork West 2016 Partnering Summit (NASDAQ:RDHL)
finance.yahoo.com - September 27 at 11:36 AM
News IconRedHill Biopharma and IntelGenx Announce RIZAPORT(R) Commercialization Term Sheet with Pharmatronic Co. for Korea (NASDAQ:RDHL)
www.stock-world.de - September 22 at 11:48 AM
finanznachrichten.de logoRedHill Biopharma Ltd.: RedHill Biopharma and IntelGenx Announce RIZAPORT® Commercialization Term Sheet with Pharmatronic Co. for Korea (NASDAQ:RDHL)
www.finanznachrichten.de - September 22 at 11:48 AM
globenewswire.com logoDGAP-News: RedHill Biopharma and IntelGenx Announce RIZAPORT(R) Commercialization Term Sheet with Pharmatronic Co. for Korea (NASDAQ:RDHL)
globenewswire.com - September 22 at 11:48 AM
streetinsider.com logoRedHill Biopharma (RDHL), IntelGenx Enters RIZAPORT Licensing Agreement for Korea (NASDAQ:RDHL)
www.streetinsider.com - September 22 at 11:48 AM
streetinsider.com logoRedHill Biopharma (RDHL), IntelGenx Enters RIZAPORT Licensing Agreement for Korea - StreetInsider.com (NASDAQ:RDHL)
www.streetinsider.com - September 21 at 6:35 PM
uk.finance.yahoo.com logoRedHill Biopharma Ltd.: RedHill Biopharma Announces Phase Ib/II Study with YELIVA(TM) Initiated for Multiple ... - Yahoo Finance UK (NASDAQ:RDHL)
uk.finance.yahoo.com - September 14 at 11:22 AM
News IconShares Gapping Lower Pre-Market: RedHill Biopharma Ltd. (NASDAQ:RDHL) - Post News (NASDAQ:RDHL)
www.kentuckypostnews.com - September 14 at 11:22 AM
streetinsider.com logoRedHill Biopharma (RDHL) Enters Research Collaboration with Stanford for YELIVA (NASDAQ:RDHL)
www.streetinsider.com - September 13 at 11:52 AM
streetinsider.com logoRedHill Biopharma (RDHL) Enters Research Collaboration with Stanford for YELIVA - StreetInsider.com (NASDAQ:RDHL)
www.streetinsider.com - September 12 at 6:39 PM
nasdaq.com logoRedHill Biopharma Announces Research Collaboration with Stanford University for YELIVA(TM) (NASDAQ:RDHL)
www.nasdaq.com - September 12 at 11:37 AM
globenewswire.com logoRedHill Biopharma Announces Research Collaboration with Stanford University for YELIVA™ (NASDAQ:RDHL)
globenewswire.com - September 12 at 11:37 AM
News IconWhat is the Street Saying About Redhill Biopharma Ltd. (NASDAQ:RDHL)? - Frisco Fastball (NASDAQ:RDHL)
friscofastball.com - September 10 at 11:09 AM
streetinsider.com logoRedHill Biopharma (RDHL) Commences YELIVA Phase 1b/2 in r/r/ Multiple Myeloma - StreetInsider.com (NASDAQ:RDHL)
www.streetinsider.com - September 8 at 6:42 PM
einnews.com logoRedHill Biopharma Announces Phase Ib/II Study with YELIVA™ Initiated for Multiple Myeloma at a Leading U.S. Academic Medical Center (NASDAQ:RDHL)
semiconductors.einnews.com - September 8 at 10:49 AM
streetinsider.com logoRedHill Biopharma (RDHL) Commences YELIVA Phase 1b/2 in r/r/ Multiple Myeloma (NASDAQ:RDHL)
www.streetinsider.com - September 8 at 10:49 AM
finance.yahoo.com logoRedHill Biopharma Announces Phase Ib/II Study with YELIVA(TM) Initiated for Multiple Myeloma at a Leading U.S. Academic Medical Center (NASDAQ:RDHL)
finance.yahoo.com - September 8 at 10:49 AM
News IconRedHill Announces Approval of a European Patent Supporting RHB-104 for Multiple Sclerosis (NASDAQ:RDHL)
www.pharmiweb.com - September 1 at 10:08 AM
finance.yahoo.com logoRedHill Biopharma to Present at the 9th Annual BioPharm America International Partnering Conference (NASDAQ:RDHL)
finance.yahoo.com - September 1 at 10:08 AM
News IconStock in Review: Taking a Closer Look at Redhill Biopharma Ltd. (NASDAQ:RDHL) Shares - Post News (NASDAQ:RDHL)
www.kentuckypostnews.com - August 31 at 12:12 PM
finance.yahoo.com logoRedHill Biopharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:RDHL)
finance.yahoo.com - August 31 at 12:12 PM
finanznachrichten.de logoRedHill Biopharma Ltd.: RedHill Biopharma Announces Approval of a European Patent Supporting RHB-104 for Multiple Sclerosis (NASDAQ:RDHL)
www.finanznachrichten.de - August 29 at 6:51 PM
streetinsider.com logoRedHill Biopharma (RDHL) Receives European Patent Related to RHB-104 (NASDAQ:RDHL)
www.streetinsider.com - August 29 at 6:51 PM
finance.yahoo.com logoRedHill Biopharma Announces Approval of a European Patent Supporting RHB-104 for Multiple Sclerosis (NASDAQ:RDHL)
finance.yahoo.com - August 29 at 6:51 PM
streetinsider.com logoRedHill Biopharma (RDHL) Receives European Patent Related to RHB-104 - StreetInsider.com (NASDAQ:RDHL)
www.streetinsider.com - August 29 at 11:38 AM
News IconRedHill Biopharma Ltd - (NASDAQ: RDHL) Stock Rating Reiterated at FBR & Co - BNB Daily (blog) (NASDAQ:RDHL)
www.baseball-news-blog.com - August 25 at 12:10 PM
News IconCan the Crowd & Analysts Agree on Redhill Biopharma Ltd. (NASDAQ:RDHL)? - Post News (NASDAQ:RDHL)
www.kentuckypostnews.com - August 24 at 10:06 AM
kcregister.com logoStocks Swings: KeyCorp. (NYSE:KEY), RedHill Biopharma Ltd. (NASDAQ:RDHL), Manulife Financial Corporation ... - KC Register (NASDAQ:RDHL)
www.kcregister.com - August 16 at 10:23 AM
globenewswire.com logoRedHill Biopharma Provides 2016 Semi-Annual R&D Update (NASDAQ:RDHL)
globenewswire.com - August 11 at 10:21 AM
capitalcube.com logoRedHill Biopharma Ltd. :RDHL-IL: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:RDHL)
www.capitalcube.com - August 9 at 10:14 AM
capitalcube.com logoRedHill Biopharma Ltd. :RDHL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:RDHL)
www.capitalcube.com - August 5 at 7:18 PM
finanznachrichten.de logoRedHill Biopharma Ltd.: RedHill Biopharma Announces Last Patient Visit in Phase IIa Study with RHB-104 for Multiple Sclerosis (NASDAQ:RDHL)
www.finanznachrichten.de - August 1 at 11:44 AM
finance.yahoo.com logoRedHill Biopharma Announces Last Patient Visit in Phase IIa Study with RHB-104 for Multiple Sclerosis (NASDAQ:RDHL)
finance.yahoo.com - August 1 at 8:08 AM
seekingalpha.com logoRedHill Biopharma: Why Analysts Think Shares Can Double (NASDAQ:RDHL)
seekingalpha.com - July 30 at 6:23 PM
insidermonkey.com logoRedHill Biopharma Ltd – ADR (RDHL) GI Topline Is Set For 2016 Release (NASDAQ:RDHL)
www.insidermonkey.com - July 28 at 11:59 AM
News IconRedHill Biopharma Ltd.: RedHill Biopharma Reports 2016 Second Quarter (NASDAQ:RDHL)
www.stock-world.de - July 28 at 10:20 AM
finance.yahoo.com logoRedHill Biopharma Reports 2016 Second Quarter Financial Results (NASDAQ:RDHL)
finance.yahoo.com - July 26 at 7:02 AM
4-traders.com logoRedHill Biopharma : Receives Additional U.S. Patent Covering RHB-105 Ahead of Confirmatory Phase III Study for H. pylori Infection (NASDAQ:RDHL)
www.4-traders.com - July 23 at 6:33 PM
streetinsider.com logoRedHill Biopharma (RDHL) Receives Additional USPTO Notice of Allowance for Patent Covering RHB-105 (NASDAQ:RDHL)
www.streetinsider.com - July 22 at 6:54 PM
News IconRedhill Biopharma Limited Ads (NASDAQ:RDHL) Shorted Shares Increased By 14.9% - Consumer Eagle (NASDAQ:RDHL)
www.consumereagle.com - July 22 at 10:00 AM
News IconEquity Roundup: Stock Performance Focus on Redhill Biopharma Ltd. (NASDAQ:RDHL) - Press Telegraph (NASDAQ:RDHL)
presstelegraph.com - July 21 at 9:56 AM
streetinsider.com logoRedHill Biopharma (RDHL) Receives Additional USPTO Notice of Allowance for Patent Covering RHB-105 - StreetInsider.com (NASDAQ:RDHL)
www.streetinsider.com - July 21 at 9:56 AM
finance.yahoo.com logoRedHill Biopharma Receives Additional U.S. Patent Covering RHB-105 Ahead of Confirmatory Phase III Study for H. pylori Infection (NASDAQ:RDHL)
finance.yahoo.com - July 21 at 9:03 AM
News IconRedHill Biopharma to Host Second Quarter 2016 Financial Results Conference Call on July 26, 2016 - P&T Community (NASDAQ:RDHL)
www.ptcommunity.com - July 19 at 7:11 PM
globenewswire.com logoRedHill Biopharma to Host Second Quarter 2016 Financial Results Conference Call on July 26, 2016 - GlobeNewswire (press release) (NASDAQ:RDHL)
globenewswire.com - July 19 at 8:02 AM
News IconRedhill Biopharma Limited Ads (NASDAQ:RDHL) Sellers Increased By 1.79% Their Shorts - Consumer Eagle (NASDAQ:RDHL)
www.consumereagle.com - July 19 at 8:02 AM
finance.yahoo.com logoRedHill Biopharma to Host Second Quarter 2016 Financial Results Conference Call on July 26, 2016 (NASDAQ:RDHL)
finance.yahoo.com - July 19 at 7:00 AM
News IconRedHill Biopharma Ltd.: RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT(TM) for M. (NASDAQ:RDHL)
www.stock-world.de - July 18 at 12:34 PM
News IconAnalyst Target and Average Rating Watch: Redhill Biopharma Ltd. (NASDAQ:RDHL) - Press Telegraph (NASDAQ:RDHL)
presstelegraph.com - July 16 at 10:19 AM

Social

RedHill Biopharma Ltd - (NASDAQ:RDHL) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff